Research Square

Continuous Glucose Monitoring-Based Metrics with Fixed-Dose Combination Versus Co-administered Dapagliflozin/Metformin in Chinese Patients with Type 2 Diabetes Mellitus

By Xuejie Dong, Jia Liu, Ying Wei, Guang Wang

Preprint: randomised trial in 305 peopleInterventions

24 weeks

The paper

Xuejie Dong, Jia Liu, Ying Wei, Guang Wang

Capital Medical University

Research Square, 29 Sep 2026, Preprint, not peer-reviewed

doi.org/10.21203/rs.3.rs-11046331/v1

Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Clinical Pharmacology and Therapeutics4 Oct 2026
SGLT2 inhibitors raise genital but not urinary infection risk
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety